Cytosorbents (CTSO) Receivables (2011 - 2026)
Cytosorbents (CTSO) recorded Receivables of $6.79 million in Q2 2026, down 52.8% from $14.38 million a year earlier and down 51.7% from the prior quarter.
Powered by 
Analysis
Cytosorbents (CTSO) Receivables (2011 - 2026) Analysis & Trends
At the end of FY2025, Cytosorbents reported Receivables of $14.68 million, up 13.6% from FY2024.
- Annual Receivables has increased for four straight years, with a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $12.92 million in FY2024 (+13.8%), $11.36 million in FY2023 (+19.7%), $9.49 million in FY2022 (+26.1%) and $7.52 million in FY2021 (-7.7%).
- The Q2 2026 figure is the lowest quarterly Receivables since Q2 2020.
- On a year-over-year basis, Receivables rose in seven of the last eight quarters, with growth averaging 2.8%.
- Peak year-over-year performance for Receivables in the last five years was growth of 26.1% in Q4 2022, against a decline of 52.8% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $14.05 million (Q1 2026), $14.68 million (Q4 2025) and $13.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 11.14 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 8.60 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 3.97 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 1.67 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 6.36 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 3.74 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 3.05 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 955.70 Mn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 2.36 Bn |
| 10 | Cytosorbents | 12.57 Mn | -10.44 Mn | 7.05 Mn | 6.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.79 Mn |
| Mar 31, 2026 | 14.05 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Sep 30, 2025 | 13.42 Mn |
| Jun 30, 2025 | 14.38 Mn |
| Mar 31, 2025 | 13.53 Mn |
| Dec 31, 2024 | 12.92 Mn |
| Sep 30, 2024 | 11.48 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 11.74 Mn |
| Dec 31, 2023 | 11.36 Mn |
| Sep 30, 2023 | 10.71 Mn |
| Jun 30, 2023 | 11.78 Mn |
| Mar 31, 2023 | 9.53 Mn |
| Dec 31, 2022 | 9.49 Mn |
| Sep 30, 2022 | 9.18 Mn |
| Jun 30, 2022 | 9.42 Mn |
| Mar 31, 2022 | 7.73 Mn |
| Dec 31, 2021 | 7.52 Mn |
| Sep 30, 2021 | 8.66 Mn |
API Access
Cytosorbents Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CTSO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CTSO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CTSO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();